Anagenics Ltd has released a press release.
Patent for Improved Midkine Antibody Allowed in Europe
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- CDY Signs Distribution Agreement for EVOLIS in South Korea
- Response to Appendix 4C Query
- Cellmid Sets Another Sales Record in Q4 FY2019
- Cellmids Evolis Registered in European Union (EU)
- Minimum Holding Share Buy-Back
Later from Anagenics
- FY2019 Financial Results
- New Evolis Distribution & Supply Agreements - China & Europe
- New TV Shopping Agreement for Evolis
- Cellmid Signs Trading Agreement With API/Priceline
- Cellmid Reports on QVC Sales
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics